BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 12867751)

  • 21. Intracellular Tat of human immunodeficiency virus type 1 activates lytic cycle replication of Kaposi's sarcoma-associated herpesvirus: role of JAK/STAT signaling.
    Zeng Y; Zhang X; Huang Z; Cheng L; Yao S; Qin D; Chen X; Tang Q; Lv Z; Zhang L; Lu C
    J Virol; 2007 Mar; 81(5):2401-17. PubMed ID: 17151125
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential regulation of the overlapping Kaposi's sarcoma-associated herpesvirus vGCR (orf74) and LANA (orf73) promoters.
    Jeong J; Papin J; Dittmer D
    J Virol; 2001 Feb; 75(4):1798-807. PubMed ID: 11160678
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Octamer-binding sequence is a key element for the autoregulation of Kaposi's sarcoma-associated herpesvirus ORF50/Lyta gene expression.
    Sakakibara S; Ueda K; Chen J; Okuno T; Yamanishi K
    J Virol; 2001 Aug; 75(15):6894-900. PubMed ID: 11435569
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human immunodeficiency virus type 1 induces lytic cycle replication of Kaposi's-sarcoma-associated herpesvirus: role of Ras/c-Raf/MEK1/2, PI3K/AKT, and NF-κB signaling pathways.
    Zhu X; Zhou F; Qin D; Zeng Y; Lv Z; Yao S; Lu C
    J Mol Biol; 2011 Jul; 410(5):1035-51. PubMed ID: 21763505
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Kaposi's sarcoma-associated herpesvirus virion-induced transcription activation of the ORF50 immediate-early promoter.
    Lu F; Day L; Lieberman PM
    J Virol; 2005 Oct; 79(20):13180-5. PubMed ID: 16189019
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification and characterization of the Orf49 protein of Kaposi's sarcoma-associated herpesvirus.
    González CM; Wong EL; Bowser BS; Hong GK; Kenney S; Damania B
    J Virol; 2006 Mar; 80(6):3062-70. PubMed ID: 16501115
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Functional analysis of Kaposi's sarcoma-associated herpesvirus RTA in an RTA-depressed cell line.
    Nishimura K; Ueda K; Sakakibara S; Ishikawa K; Chen J; Okuno T; Yamanishi K
    J Hum Virol; 2001; 4(6):296-305. PubMed ID: 12082396
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Kaposi's sarcoma-associated herpesvirus-encoded latency-associated nuclear antigen inhibits lytic replication by targeting Rta: a potential mechanism for virus-mediated control of latency.
    Lan K; Kuppers DA; Verma SC; Robertson ES
    J Virol; 2004 Jun; 78(12):6585-94. PubMed ID: 15163750
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Induction of lytic cycle replication of Kaposi's sarcoma-associated herpesvirus by herpes simplex virus type 1: involvement of IL-10 and IL-4.
    Qin D; Zeng Y; Qian C; Huang Z; Lv Z; Cheng L; Yao S; Tang Q; Chen X; Lu C
    Cell Microbiol; 2008 Mar; 10(3):713-28. PubMed ID: 18042256
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CREB-binding protein and histone deacetylase regulate the transcriptional activity of Kaposi's sarcoma-associated herpesvirus open reading frame 50.
    Gwack Y; Byun H; Hwang S; Lim C; Choe J
    J Virol; 2001 Feb; 75(4):1909-17. PubMed ID: 11160690
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Autoregulation of DNA binding and protein stability of Kaposi's sarcoma-associated herpesvirus ORF50 protein.
    Chang PJ; Miller G
    J Virol; 2004 Oct; 78(19):10657-73. PubMed ID: 15367633
    [TBL] [Abstract][Full Text] [Related]  

  • 32. De novo protein synthesis is required for lytic cycle reactivation of Epstein-Barr virus, but not Kaposi's sarcoma-associated herpesvirus, in response to histone deacetylase inhibitors and protein kinase C agonists.
    Ye J; Gradoville L; Daigle D; Miller G
    J Virol; 2007 Sep; 81(17):9279-91. PubMed ID: 17596302
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Kaposi's-sarcoma-associated herpesvirus orf35 gene product is required for efficient lytic virus reactivation.
    Bergson S; Itzhak I; Wasserman T; Gelgor A; Kalt I; Sarid R
    Virology; 2016 Dec; 499():91-98. PubMed ID: 27639575
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of human herpesvirus 8 (HHV-8)-encoded immediate early protein, open reading frame 50, in HHV-8-associated diseases.
    Katano H; Sato Y; Itoh H; Sata T
    J Hum Virol; 2001; 4(2):96-102. PubMed ID: 11437319
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Kaposi's sarcoma-associated herpesvirus ori-Lyt-dependent DNA replication: cis-acting requirements for replication and ori-Lyt-associated RNA transcription.
    Wang Y; Li H; Chan MY; Zhu FX; Lukac DM; Yuan Y
    J Virol; 2004 Aug; 78(16):8615-29. PubMed ID: 15280471
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Human immunodeficiency virus replication in a primary effusion lymphoma cell line stimulates lytic-phase replication of Kaposi's sarcoma-associated herpesvirus.
    Varthakavi V; Browning PJ; Spearman P
    J Virol; 1999 Dec; 73(12):10329-38. PubMed ID: 10559351
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transcriptome analysis of Kaposi's sarcoma-associated herpesvirus during de novo primary infection of human B and endothelial cells.
    Purushothaman P; Thakker S; Verma SC
    J Virol; 2015 Mar; 89(6):3093-111. PubMed ID: 25552714
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Kaposi's sarcoma-associated herpesvirus (human herpesvirus-8) ORF54 encodes a functional dUTPase expressed in the lytic replication cycle.
    Kremmer E; Sommer P; Holzer D; Galetsky SA; Molochkov VA; Gurtsevitch V; Winkelmann C; Lisner R; Niedobitek G; Gr Sser FA
    J Gen Virol; 1999 May; 80 ( Pt 5)():1305-1310. PubMed ID: 10355777
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Activation of the Kaposi's sarcoma-associated herpesvirus major latency locus by the lytic switch protein RTA (ORF50).
    Matsumura S; Fujita Y; Gomez E; Tanese N; Wilson AC
    J Virol; 2005 Jul; 79(13):8493-505. PubMed ID: 15956592
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Kaposi's sarcoma-associated herpesvirus (KSHV) Rta and cellular HMGB1 proteins synergistically transactivate the KSHV ORF50 promoter.
    Harrison SM; Whitehouse A
    FEBS Lett; 2008 Sep; 582(20):3080-4. PubMed ID: 18692049
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.